Hydrolysis by plasma kallikrein of fluorogenic peptides derived from prorenin processing site

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1479, Issue 1-2, 2000, Pages 83-90

  Almeida, Paulo Cezar ^a   Chagas, Jair Ribeiro ^a   Cezari, Maria Helena Sedenho ^a   Juliano, Maria Aparecida ^a   Juliano, Luiz ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fluorogenic substrate; Prorenin; Renin; Tissue kallikrein

Indexed keywords

FLUORESCENT DYE; PEPTIDE; PLASMA KALLIKREIN; PRORENIN; TRYPSIN;

ARTICLE; ENZYME ACTIVATION; ENZYME SPECIFICITY; HUMAN; HYDROLYSIS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; REACTION ANALYSIS; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; CATTLE; ENZYME PRECURSORS; HUMANS; HYDROLYSIS; KALLIKREINS; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; RENIN; SEQUENCE HOMOLOGY, AMINO ACID;

BOVINAE; FELIS CATUS;

EID: 0034660081     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(00)00049-2     Document Type: Article

References (46)

1. Hsueh W.A., Baxter J.D. Human prorenin. Hypertension. 17:1991;469-477.
2. Brechler V., Chu W.N., Baxter J.D., Thibault G., Reudelhuber T.L. A protease processing site is essential for prorenin sorting to the regulated secretory pathway. J. Biol. Chem. 271:1996;20636-20640.
3. Derkx F.H.M., Schalecamp M.A.D.H. Human prorenin: pathophysiology and clinical applications. Clin. Exp. Hypertens. 97:1988;1213-1225.
4. Danser A.H.J., van Katz J.P., Admiraal P.J.J., Derkx F.H.M., Lamers J.M.J., Verdouw P.D., Saxena P.R., Schalecamp M.A.D.H. Cardiac renin and angiotensins: uptake from plasma versus in situ synthesis. Hypertension. 24:1994;37-48.
5. van Kesteren C.A.M., Saris J.J., Dekkers D.H.W., Lamers J.M.J., Saxena P.R., Schalecamp M.A.D.H., Danser A.H.J. Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II. Cardiovasc. Res. 43:1999;148-156.
6. Ganong W.F. Blood, pituitary and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland. Front Neuroendocrinol. 14:1993;233-249.
7. Fukuda N., Satoh C., Hu W.-Y., Soma M., Kubo A., Kishioka H., Watanabe Y., Izumi Y., Kanmatsuse K. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Artrioscler. Thromb. Vasc. Biol. 19:1999;1210-1217.
8. Dzau V.J., Brody T., Elison K.E., Pratt R.E., Infilger J.R. Tissue-specific regulation of renin expression in the mouse. Hypertension. 9:1987;36-41.
9. Campbell D.J., Habener J.F. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J. Clin. Invest. 78:1986;31-39.
10. D.H. Osmond, E.K. Lo, A.Y. Loh, E.A. Zingg, A.H. Hedlin, Kallikrein and plasmin as activators of renin. Lancet (1978) 1375-1376.
11. Sealey J.E., Atlas S.A., Laragh J.H., Silverberg M., Kaplan A.P. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein. Proc. Natl. Acad. Sci. USA. 76:1979;5914-5918.
12. Derkx F.H.M., Bouma B.N., Schalekamp M.P.A., Schalekamp M.A.D.H. An intrinsic factor XII-prekallikrein-dependent pathway activates the human plasma renin-angiotensin system. Nature. 280:1979;315-316.
13. Rumpf K.W., Becker K., Kreusch U., Schmidt S., Vetter R., Scheler F. Evidence for a role of plasma kallikrein in the activation of prorenin. Nature. 283:1980;482-482.
14. Yokosawa N., Takahashi N., Inagami T., Page D.L. Isolation of completely inactive plasma prorenin and its activation by kallikreins. A possible new link between renin and kallikrein. Biochim. Biophys. Acta. 569:1979;211-219.
15. F.H.M. Derkx, B.N. Bouma, H.L. Tan Tjiong, A.J. Man in 't Veld, J.H. de Bruyn, G.J. Wenting, M.A. Schalekamp, The plasma kallikrein-renin connection. Arch. Int. Pharmacodyn. Ther. Suppl. (1980) 165-177.
16. Derkx F.H.M., Bouma B.N., Tan-Tjiong H.L., Man in 't Veld A.J., de Bruyn J.H., Wenting G.J., Schalekamp M.A. Role of plasma kallikrein in the proteolytic activation of the renin-angiotensin system. Clin. Exp. Hypertens. 2:1980;575-592.
17. Schalekamp M.A.D.H., Derkx F.H.M. Plasma kallikrein and plasmin as activators of prorenin: Links between the renin-angiotensin system and other proteolytic systems in plasma. Clin. Sci. 61:1981;15-21.
18. Derkx F.H.M., Bouma B.N., Schalekamp M.P.A. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors. J. Lab. Clin. Med. 103:1984;560-573.
19. Derkx F.H.M., Schalekamp M.P., Bouma B., Kluft C., Schalekamp M.P.A. Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin. J. Clin. Endocrinol. Metab. 54:1982;343-348.
20. Motta G., Rojkjaer R., Hasan A.A.K., Cines D.B., Schimaier A.H. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation. Blood. 91:1998;516-528.
21. Rojkjaer R., Schimaier A.H. Activation of plasma kallikrein/kinin system on endothelial cells. Proc. Assoc. Am. Phys. 111:1999;220-227.
22. Kim S., Hosoi M., Kikuchi N., Yamamoto K. Amino-terminal amino acid sequence and heterogeneity in glycosylation of rat renal renin. J. Biol. Chem. 266:1991;7044-7050.
23. Campbell D.J., Valentijn A.J., Condron R. Purification and amino-terminal sequence of rat kidney renin: evidence for a two-chain structure. J. Hypertens. 9:1991;29-33.
24. de Keijzer M.H., Provoost A.P., Derkx F.H.M. Absence of activation in vitro of renin in rat plasma. Clin. Sci. 62:1982;435-437.
25. Vincent P.A., De Vito E. Rat renal and plasma prorenin are activated in vitro by different mechanisms. Hypertension. 34:1999;520-524.
26. Hirata I.Y., Cezari M.H.S., Nakaie C.R., Boschcov P., Ito A.S., Juliano M.A., Juliano L. Internally quenched fluorogenic proteases substrates: solid-phase peptide synthesis and fluorescence spectroscopy of peptides containing ortho-amino-aminobenzoyl/dinitro phenyl groups as donor-acceptor pairs. Lett. Pept. Sci. 1:1994;299-308.
27. Chagas J.R., Juliano L., Prado E.S. Intramolecularly quenched fluorogenic tetrapeptide substrates for tissue and plasma kallikreins. Anal. Biochem. 192:1990;419-425.
28. Oliva M.L., Grisolia D., Sampaio M.U., Sampaio C.A.M. Agents Actions Suppl. 9:1982;52-57.
29. Kouyoumdjian M., Borges D.R., Michelacci Y.M., Guimarães J.A., Sampaio C.A.M., Prado J.L. Purification and characterization of the alpha form of rat plasma kallikrein. Braz. J. Med. Biol. Res. 20:1987;549-552.
30. Sampaio C.A.M., Sampaio M.U., Prado E.S. Active-site titration of horse urinary kallikrein. Hoppe-Seylers Z. Physiol. Chem. 365:1984;297-302.
31. Chase J.T., Shaw E. Titration of trypsin, plasmin and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl. Methods Enzymol. 19:1970;20-22.
32. Dias C.L.F., Rogana E. Autolysis of β-trypsin at pH 3.0. Braz. J. Med. Biol. Res. 19:1986;11-18.
33. Pimenta D.C., Chao J., Chao L., Juliano M.A., Juliano L. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids. Biochem. J. 339:1999;473-479.
34. Wilkinson G.N. Statistical estimations in enzyme kinetics. Biochem. J. 80:1961;324-332.
35. Chu W.N., Mercure C., Baxter J.D., Reudelhuber T.L. Molecular determinants of human prorenin processing. Hypertension. 20:1992;782-787.
36. Urata H., Kinoshita A., Misono K.S., Bumpus F.M., Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265:1990;22348-22357.
37. Mercure C., Jutras I., Day R., Seidah N.G., Reudelhuber T.L. Prohormone convertase PC5 is a candidate processing enzyme for prorenin in the human adrenal cortex. Hypertension. 28:1996;840-846.
38. Laframboise M., Reudelhuber T.L., Justras I., Brechler V., Seidah N.G., Day R., Gross K.W., Deschepper C.F. Prorenin activation and prohormone convertases in the mouse As4.1 cell line. Kidney Int. 51:1997;104-109.
39. Wang P.H., Do Y.S., Macaulay L., Shinagawa T., Anderson P.W., Baxter J.D., Hsueh W.A. Identification of renal cathepsin B as a human prorenin-processing enzyme. J. Biol. Chem. 266:1991;12633-12638.
40. Neves F.A., Duncan K.G., Baxter J.D. Cathepsin B is a prorenin processing enzyme. Hypertension. 27:1996;514-517.
41. Derkx F.H.M., Schalecamp M.A.D.H. Human prorenin: pathophysiology and clinical applications. Clin. Exp. Hypertens. 97:1988;1213-1225.
42. Craik C.S., Largman C., Fletcher T., Barr P., Fletterick R., Rutter W.J. Redesigning trypsin: alteration of substrate specificity, catalytic activity and protein conformation. Science. 228:1985;291-297.
43. Vincent P.A., De Vito E. Rat renal and plasma prorenin are activated in vitro by different mechanisms. Hypertension. 34:1999;520-524.
44. Xu Q.A., Buckley D., Guan C.D., Guo H.C. Structural insights into the mechanism of intramolecular proteolysis. Cell. 98:1999;651-661.
45. Ridker P.M., Gaboury C.L., Conlin P.R., Seely E.W., Williams G.H., Vaughan D.E. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation. 87:1993;1969-1973.
46. Vaughan D.E. The renin-angiotensin system and fibrinolysis. Am. J. Cardiol. 79:1997;12-16.